# Robert Mittendorff

> Dr. Robert Mittendorff is General Partner and Global Head of Healthcare at B Capital, one of the world's leading multi-stage global investment firms with over $6 billion in assets under management. An MD, MBA, and biomedical engineer rolled into one, he brings the rare combination of clinical credibility, operating experience, and investment acumen to healthcare venture capital. He led B Capital's inaugural $500M+ Healthcare Fund I, backing category-defining companies across digital health, medtech, biotech, and AI-driven healthcare from seed to IPO.

- **Role:** General Partner and Global Head of Healthcare at B Capital
- **Organizations:** B Capital, Norwest Venture Partners, Hansen Medical, BCG, Merck, Kaiser Permanente
- **Nationality:** American
- **Education:** BS in Biomedical Engineering (High Honors), Johns Hopkins University, SM in Systems Engineering (Fellowship), MIT, MD, Harvard Medical School, Emergency Medicine Residency, Stanford University, MBA (Fellowship), Harvard Business School, MA in International Affairs, King's College London, Fellowship, Howard Hughes Medical Institute
- **Known for:** Led B Capital Healthcare Fund I to close at over $500 million (March 2023), Invested in and exited healthcare companies with combined public equity or acquisition value exceeding $10 billion, Early investor in Misfit Wearables (acquired by Fossil Group), Health Catalyst (HCAT public), and iRhythm Technologies

## Career timeline

- **2000s** — Management consultant at Boston Consulting Group (BCG)
- **2000s** — Portfolio strategy role at Merck
- **2000s** — Emergency physician at Kaiser Permanente
- **2000s-2010s** — VP of Marketing and Business Development at Hansen Medical Inc. (Nasdaq: HNSN); launched Magellan and Sensei X surgical robots; led partnerships with GE, Siemens, Philips, St. Jude Medical
- **2012** — Joined Norwest Venture Partners as Partner and Co-Head of Healthcare
- **2012-2021** — Nearly a decade at Norwest Venture Partners; backed companies including Misfit Wearables, Health Catalyst, iRhythm Technologies; exits exceeding $10B in value
- **2021-04** — Joined B Capital as General Partner and Global Head of Healthcare
- **2023-03** — Led close of B Capital Healthcare Fund I; over $500M committed across Healthcare Fund I and Growth Fund III
- **2025** — Board member at ARTBIO (Series B, $130M round, Jul 2025); Judi Health (Series F, $250M round, Sep 2025); Precision Neuroscience and others

## Achievements

- Led B Capital Healthcare Fund I to close at over $500 million (March 2023)
- Invested in and exited healthcare companies with combined public equity or acquisition value exceeding $10 billion
- Early investor in Misfit Wearables (acquired by Fossil Group), Health Catalyst (HCAT public), and iRhythm Technologies
- Launched Magellan and Sensei X surgical robots at Hansen Medical (acquired by Auris/Johnson & Johnson)
- Fellow of the American Academy of Emergency Medicine (FAAEM)
- Leadership Fellow at Johns Hopkins University
- Co-chair, Digital Healthcare Innovation Summit
- Varsity athlete at Johns Hopkins University

## Latest updates

- **2025-09** — Board member at Judi Health following its $250M Series F round
- **2025-07** — Board member at ARTBIO following its $130M Series B round
- **2023-03** — Led B Capital Healthcare Fund I close at over $500M committed to healthcare innovation

## Links

- Website: https://b.capital/team/robert-mittendorff/
- LinkedIn: http://www.linkedin.com/in/robertmittendorffmd
- Facebook: https://facebook.com/bcapitalgroup

---

Profile page: https://yespress.io/robert-mittendorff
Published by YesPress — https://yespress.io
Last updated: 2026-05-17